Update Venetoclax in CLL
Obinutuzumab
Acalabrutinib
Zanubrutinib
NCCN Guidelines for Patients for CLL
UpToDate
NCCN Guidelines for Patients
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL